Park Vale Capital

investment firm

About

Park Vale Capital is an alternative investment firm dedicated to managing assets on behalf of institutions and foundation.

Details

Industries
Finance,Financial Services,Venture Capital
Operating Status
Active
Legal Name
Park Vale Capital Limited
Also Known As
Lincoln Vale LLP
Investor Type
Venture Capital

Park Vale Capital is an investment firm that is dedicated to developing and managing fiduciary long term capital in a number of specific, unusual and focused investment strategies.

Park Vale advice and provide high-value investment products through direct deal opportunities, funds, and tailor-made investment solutions. Park Vale is built on the pursuit of unusual (low correlation to traditional assets), risk-adjusted positive performance which is designed to drive meaningful out performance in the total asset allocation.

Park Vale operate from offices in London, New York, Hong Kong and Shanghai to ensure we are able to source and manage our networks, information and deal flow.

Park Vale and it’s partners are experienced professionals with expertise in private equity, Biotechnology, China Special Situations, Real Estate Opportunities, Adaptive Strategies, New Technology, Global Energy, and JABCAP (LUX).

Investments

Number of Investments
Number of Lead Investments
3
1
Park Vale Capital has made 3 investments. Their most recent investment was on Oct 3, 2017, when Cullinan Oncology raised $150M.
Date Company Name
Round Money Raised Industry Lead Investor
Series A $150M Biopharma
Series Unknown £16M CleanTech Yes
Aug 25, 2015 Causemo
Series A $4M Big Data

Exits

Park Vale Capital has had 2 exits. Park Vale Capital most notable exits include Cullinan Oncology ,   Causemo

Date Company Name Exit Type Industry
Jan 7, 2021 Cullinan Oncology IPO Biopharma Detail
Aug 14, 2019 Causemo M&A Big Data Detail